Maravai Lifesciences Holdings (MRVI) Receivables - Other (2020 - 2024)

Maravai Lifesciences Holdings' Receivables - Other history runs 4 years deep, the most recent figure standing at -$676000.0 for Q4 2024.

• On a quarterly basis, Receivables - Other rose 71.95% year-over-year to -$676000.0 in Q4 2024; TTM through Dec 2025 was $2.2 million, a 479.68% increase from a year earlier, with the FY2024 full-year figure at $734000.0, down 34.35% from the prior year.
• Receivables - Other declined to -$676000.0 in Q4 2024 per MRVI's latest filing, from $2.8 million in the prior quarter.
• Across five years, Receivables - Other topped out at $2.8 million in Q1 2024 and bottomed at -$2.4 million in Q4 2023.
• The 4-year median for Receivables - Other is $408000.0 (2020), against an average of $262333.3.
• Biggest YoY gain for Receivables - Other was 361.69% in 2024; the steepest drop was 71.95% in 2024.
• Year by year, Receivables - Other stood at $200000.0 in 2020, then jumped by 400.0% to $1.0 million in 2021, then plunged by 341.0% to -$2.4 million in 2023, then surged by 71.95% to -$676000.0 in 2024.
• Per Business Quant, the three latest MRVI Receivables - Other figures stand at -$676000.0 (Q4 2024), $2.8 million (Q1 2024), and -$2.4 million (Q4 2023).